"There's a small wrinkle: the US Food and Drug Administration has yet to officially approve this medication - technically called retatrutide but cheekily nicknamed a "GLP-3" by users - because it's still in clinical trials. So the market for it is black, or at least severely grey, with shady overseas companies exploiting a legal loophole to get around regulatory barriers."
"In other words, everyone taking retatrutide is basically taking part in an unregulated experiment that could have disastrous results. Sure, you can effortlessly melt off the pounds with the synthetic peptide, but some users have reported disturbing side effects - such as dysesthesia, when your body processes normal sensations but you perceive them as painful, similar to the nerve pain diabetics feel in their feet."
"These substances, often manufactured in China, have become wildly popular in recent years for their purported anti-aging and longevity boosting potential, among other miraculous claims. Companies that sell these drugs are able to skirt federal regulations by writing all over their website that the compounds are not for human consumption and are instead meant for research lab purposes - advice that users are pretty clearly not following."
Some people who hit a weight-loss plateau on GLP-1 agonists are turning to retatrutide (nicknamed "GLP-3") for far greater weight loss, including reports of more than 70 pounds. Retatrutide remains unapproved and in clinical trials, so supply comes from black or gray markets and overseas vendors exploiting legal loopholes. Many of these peptides are manufactured in China and marketed as "research" compounds not for human consumption to evade regulation. Users are essentially participating in unregulated experiments and have reported troubling side effects such as dysesthesia. Medical experts warn that formulations are unknown and that these unregulated drugs carry unpredictable, potentially serious risks.
Read at Futurism
Unable to calculate read time
Collection
[
|
...
]